Skip to main content
Figure 4 | Journal of Translational Medicine

Figure 4

From: Specific targeting of whole lymphoma cells to dendritic cells ex vivo provides a potent antitumor vaccine

Figure 4

Eradication of established A20 lymphomas by DC that were pulsed with the indicated reagents. (a) Effect of loading DC with different formulations of the purified soluble A20 Id. (b) Effect of loading DC with whole unmodified lymphoma cells (A20) or with trioma cells (BiV) or with a mixture of A20 cells and purified BiV heterodimeric Ig. The difference between the trioma cell-treated group and the control group without therapy was significant with p < 0.05 (logrank test).

Back to article page